AbbVie Inc.

ABBV
NYSE
Last Updated: 12/5/2022 9:03:13 PM
Price
163.94
Changes
0.28
% Change
0.17
Volume
4572714
52 Week
High
175.91
52 Week
Low
119.21
About AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
AbbVie Inc. Company Details
CEO:   Mr. Richard Gonzalez
Country:   US
Industry:   Drug Manufacturers—General
Website:   https://www.abbvie.com
Exchange:   New York Stock Exchange
IPO\Launch Date:   2013-01-02
AbbVie Inc. Company Executive Details
  Mr. Jeffrey Ryan Stewart
  Executive Vice President & Chief Commercial Officer
  Mr. Henry O. Gosebruch
  Executive Vice President & Chief Strategy Officer
  Mr. Timothy J. Richmond
  Executive Vice President & Chief HR Officer
  Ms. Elizabeth Shea
  Vice President of Investor Relations
  Dr. Thomas J. Hudson
  Senior Vice President of R&D and Chief Scientific Officer

AbbVie Inc. Latest News

Relative Strength Found Within These 3 Medical Stocks


The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.


Published on: 2022-12-05 18:48:10

Impact on Symbol / Company: ABBV

View News

The 7 Best Dividend Stocks to Buy for Your Grandkids in 2023


If you're looking for some of the best dividend stocks for grandkids, try these. Over time, companies that pay dividends can help investors compound their returns.


Published on: 2022-12-05 16:51:38

Impact on Symbol / Company: ABBV

View News

Is AbbVie Stock a Smart Contrarian Pick for 2023?


The pharma giant's story won't be over with anticipated sales declines for its top-selling drug.


Published on: 2022-12-05 05:57:00

Impact on Symbol / Company: ABBV

View News

Here's How to Prepare Your Portfolio for 2023


Efforts now could result in gains next year and beyond.


Published on: 2022-12-04 06:00:00

Impact on Symbol / Company: ABBV

View News

3 Stocks to Buy Hand Over Fist in December


These stocks could be big winners.


Published on: 2022-12-03 07:31:00

Impact on Symbol / Company: ABBV

View News

Top Stocks In Multiple Industries Build Bases As Market Gains Strength


An array of top stocks in a wide variety of industries are building cup bases as the stock market recovers. The post Top Stocks In Multiple Industries Build Bases As Market Gains Strength appeared first on Investor's Business Daily.


Published on: 2022-12-02 15:01:17

Impact on Symbol / Company: ABBV

View News

Stocks To Invest In Right Now? 3 Biotech Stocks To Watch


Is now a good time to add these biotech stocks to your watchlsit?


Published on: 2022-12-02 12:19:06

Impact on Symbol / Company: ABBV

View News

AbbVie Inc. (ABBV) Management Presents at Piper Sandler 34th Annual Healthcare Conference (Transcript)


AbbVie Inc. (NYSE:ABBV ) Piper Sandler 34th Annual Healthcare Conference Transcript December 1, 2022 9:30 AM ET Company Participants Rob Michael - Vice Chairman and President Jeff Stewart - Executive Vice President and CCO Tom Hudson - Chief Scientific Officer Scott Reents - Chief Financial Officer Conference Call Participants Chris Raymond - Piper Sandler Chris Raymond Okay. We are going to go ahead and get started.


Published on: 2022-12-01 13:46:06

Impact on Symbol / Company: ABBV

View News

Gurus Prescribed These Health Care Stocks in the 3rd Quarter


Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morning.


Published on: 2022-11-30 17:31:29

Impact on Symbol / Company: ABBV

View News

Top Dividend Stocks: Leading Biotech AbbVie Hikes Payout


With a long track record of payouts, top dividend stock AbbVie is once again in focus, generating a strong yield with stable fundamentals The post Top Dividend Stocks: Leading Biotech AbbVie Hikes Payout appeared first on Investor's Business Daily.


Published on: 2022-11-30 14:29:26

Impact on Symbol / Company: ABBV

View News

3 Top Dividend Kings to Buy for the Long Haul


Dividend stocks are an easy option to boost income.


Published on: 2022-11-30 08:05:00

Impact on Symbol / Company: ABBV

View News

AbbVie Inc. (ABBV) 5th Annual Evercore ISI HealthCONx Conference 2022 - (Transcript)


AbbVie Inc. (NYSE:ABBV ) 5th Annual Evercore ISI HealthCONx Conference Call November 29, 2022 10:55 AM ET Company Participants Jeff Stewart - Chief Commercial Officer Scott Reents - Chief Financial Officer Conference Call Participants Gavin Clark-Gartner - Evercore ISI Gavin Clark-Gartner All right. Welcome, everyone.


Published on: 2022-11-29 13:57:03

Impact on Symbol / Company: ABBV

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you